Scopus
YÖKSİS Eşleşti
PSMA Accumulation in Lower Extremity Lymphedema and Hydrocele
Clinical Nuclear Medicine · Mart 2025
YÖKSİS Kayıtları
PSMA Accumulation in Lower Extremity Lymphedema and Hydrocele
Clinical Nuclear Medicine · 2025 SCI
DOÇENT HASAN ÖNNER →
Makale Bilgileri
DergiClinical Nuclear Medicine
Yayın TarihiMart 2025
Cilt / Sayfa50 · 273-274
Scopus ID2-s2.0-85213026912
Özet
The development of radiolabeled small-molecule prostate-specific membrane antigen (PSMA) inhibitors has advanced molecular imaging in prostate cancer. The use of 177Lu-PSMA is especially beneficial because its therapeutic β-emission combined with γ-radiation enables precise treatment and comprehensive imaging in patients with prostate cancer. We present a case of a prostate cancer patient who developed lower extremity lymphedema and hydrocele secondary to prior radiotherapy. Posttherapy whole-body imaging following 177Lu-PSMA treatment revealed dermal backflow with a notable accumulation of soft tissue in the lower extremities and hydrocele.
Yazarlar (3)
1
Merve Nida Calderon Tobar
2
L. Perktaş
3
H. Önner
ORCID: 0000-0003-1002-2097
Anahtar Kelimeler
177 Lu
hydrocele
lower extremity lymphedema
PSMA
Kurumlar
Selçuk Tip Fakültesi
Konya Turkey